Skip to main content
Clinical Trials/NL-OMON30939
NL-OMON30939
Completed
Not Applicable

Cost effectiveness analysis Telemonitoring in Heart Failure - TEHAF 2

Academisch Ziekenhuis Maastricht0 sites390 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
heart failure - heart decompensation
Sponsor
Academisch Ziekenhuis Maastricht
Enrollment
390
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient \> 18 years;
  • Patients with heart failure NYHA classification II\-III\-IV;
  • patient experienced a period of fluid retention;
  • Patient is treated by a cardiologist;
  • Patient is followed\-up by a heart failure nurse;
  • Adequate level of the Dutch language;
  • Patient has an active telephone connection, preferably analogue ;
  • Patient is mental competent;
  • Patient has the disposal of a balance.

Exclusion Criteria

  • Patients suffers from COPD, Gold classification 3 or 4
  • patient is a dialysis patient;
  • Patient has a visual restriction to read the dialogues on the Health Buddy;
  • Patient is hard of hearing or deaf;
  • Patient suffers from a lethal sickness with a prognosis \< 1 year;
  • Patient participates in another trial;
  • Patient needs a hospital admission on short time, i.e. \< 3 months;
  • Patient used the Health Buddy in an earlier stage;
  • Patient is an illiterate person.

Outcomes

Primary Outcomes

Not specified

Similar Trials